Cardiopulmonary bypass and serum thyroid hormone profile in pediatric patients with congenital heart disease

Congenit Heart Dis. 2012 Sep-Oct;7(5):433-40. doi: 10.1111/j.1747-0803.2012.00667.x. Epub 2012 May 22.

Abstract

Objective: To study the effect of cardiopulmonary bypass (CPB) on serum thyroid hormone profile in children undergoing open-heart surgery.

Design: Prospective cross-sectional study.

Setting: Multispecialty tertiary level referral center.

Patients: One hundred consecutive patients (age 15.9 ± 14.6 months, weight 6.7 ± 2.5 kg) undergoing open-heart surgery under CPB.

Interventions: None.

Outcome measures: Levels and trends of serum total thyroxine (TT4), free thyroxine (FT4), total tri-iodothyronine (TT3), free tri-iodothyronine (FT3) and thyroid stimulating hormone (TSH), survival, inotropic score, duration of mechanical ventilation, postoperative complications.

Results: TT4 levels were 9.08 ± 3.6, 6.4 ± 2.5, 6.24 ± 2.1, 6.43 ± 2.4, 7.20 ± 3.0 µg/dL at baseline and at 1, 24, 48 and 72 hours; FT4 levels were 1.82 ± 0.5, 1.49 ± 0.3, 1.29 ± 0.3, 1.32 ± 0.4, and 1.43 ± 0.5 ng/dL; TT3 levels were 1.81 ± 0.4, 1.31 ± 0.3, 0.99 ± 0.2, 1.0 ± 0.37, and 1.17 ± 0.48 ng/ml; FT3 levels were 4.09 ± 1.0, 3.02 ± 0.8, 2.21 ± 0.6, 2.22 ± 0.7, and 2.66 ± 1.05 pg/ml; TSH levels were 5.40 ± 3.8, 2.0 ± 3.1, 1.24 ± 1.1, 2.90 ± 3.3, and 4.03 ± 3.4 mIU/L. There was significant fall (29.1% for FT4, 32.1% for TT4, 77% for TSH, 46% for FT3 and 45% for TT3, p < 0.0001). When area under curve (AUC) TT4 was compared between survivors (n = 87) and nonsurvivors (n = 12), significantly larger AUC was seen in survivors (492.81 ± 158.6) than nonsurvivors (360.75 ± 179.6 p = 0.0125). In survivors >72 hours, AUC TT4 was larger in patients with uneventful postoperative course versus those with postoperative complications (516.48 ± 18.6 vs. 394.78 ± 29.9, p = 0.001). AUC TT4 showed significant inverse correlation with inotropic score and borderline inverse correlation with duration of mechanical ventilation.

Conclusion: Children undergoing surgery under CPB showed significant fall in thyroid hormones. Because TT4 level is modifiable, prophylactic administration of TT4 for improving outcomes needs to be studied further.

MeSH terms

  • Area Under Curve
  • Biomarkers / blood
  • Cardiac Surgical Procedures* / adverse effects
  • Cardiac Surgical Procedures* / mortality
  • Cardiopulmonary Bypass* / adverse effects
  • Cardiopulmonary Bypass* / mortality
  • Cardiotonic Agents / therapeutic use
  • Child
  • Child, Preschool
  • Cross-Sectional Studies
  • Down-Regulation
  • Female
  • Heart Defects, Congenital / blood
  • Heart Defects, Congenital / mortality
  • Heart Defects, Congenital / surgery*
  • Humans
  • Infant
  • Infant, Newborn
  • Linear Models
  • Male
  • Postoperative Complications / blood
  • Postoperative Complications / etiology
  • Postoperative Complications / therapy
  • Prospective Studies
  • Respiration, Artificial
  • Tertiary Care Centers
  • Thyroid Hormones / blood*
  • Thyrotropin / blood
  • Thyroxine / blood
  • Time Factors
  • Treatment Outcome
  • Triiodothyronine / blood

Substances

  • Biomarkers
  • Cardiotonic Agents
  • Thyroid Hormones
  • Triiodothyronine
  • Thyrotropin
  • Thyroxine